Skip to content
Valerio Therapeutics
  • About Us
    • Profile
    • Management
    • Board of Directors
    • Scientific Advisors
    • Careers
    • Contact
  • Our Science
    • Platform
      • platON™
    • Pipeline
      • Overview
      • DDR Targeting Molecules
        • AsiDNA™
        • VIO-01
      • DecoyTAC Molecules
    • Success
      • Belinostat
  • Investor Relations
    • Presentations
    • Press Releases
    • Registration Documents
    • Shares and Voting Rights
    • Financial Information
    • Financial Operations
    • General Meetings
    • Terms and Conditions
  • Subsidiaries
    • Valour Bio
  • English
    • English
    • Français

Le Journal des Biotechs | Interview of Shefali Agarwal, President and CEO of Onxeo (in French)

Le Journal des Biotechs | Interview of Shefali Agarwal, President and CEO of Onxeo (in French)

Previous Next
Le Journal des Biotechs | Interview of Shefali Agarwal, President and CEO of Onxeo (in French)
jason2023-11-22T15:16:34-05:00

Related Posts

Valerio Therapeutics: 16.8 million euros in cash, visibility until the 2nd quarter of 2024
Valerio Therapeutics: , largest increase in the SRD market at mid-session

The platON™ Platform

Pioneering the Future of Therapeutics

1 Hartwell Place
Suite 305
Lexington, MA 02421
+1.617.366.1022

49, boulevard du Général Martial Valin
75015 PARIS – FRANCE
+33 (0) 1 70 38 33 99

Copyright © 2024 Valerio Therapeutics, All Rights Reserved

Page load link
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Go to Top